Last edition
News about "Antibody Drug Conjugates (ADC)"
Sofinnova Partners Announces Myricx Bio Agrees to Be Acquired by Novartis
Sofinnova Partners announced that portfolio company Myricx Bio has agreed to be acquired by Novartis, strengthening the company's oncology pipeline and ADC capabilities.
Antibody Drug Conjugates (ADC) | 06/07/2026 | By Akanki
Daiichi Sankyo Unveils 5-Year Oncology Growth Strategy
Daiichi Sankyo launches a 5-year strategy targeting global oncology leadership, aiming for 2.3 trillion yen in oncology revenue by 2030 through new indications, breakthrough technologies, and expanded commercialisation capabilities.
Antibody Drug Conjugates (ADC) | 12/05/2026 | By News Bureau | 230
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy